Dilazep
Dilazep is an inhibitor of adenosine uptake. Dilazep has cerebral and coronary vasodilating action through enhancement of effect of adenosine. Dilazep also inhibits the ischemic damage, platelet aggregation, and membrane transport of nucleosides[1][2].
Product Specifications
CAS Number
35898-87-4
UNSPSC
12352005
Target
Nucleoside Transporters
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(C1=CC(OC)=C(OC)C(OC)=C1)OCCCN2CCN(CCCOC(C3=CC(OC)=C(OC)C(OC)=C3)=O)CCC2
Molecular Formula
C31H44N2O10
Molecular Weight
604.69
References & Citations
[1]Zhang Y, et al. Dilazep potentiation of adenosine-mediated superior mesenteric arterial vasodilation. J Pharmacol Exp Ther. 1991 Sep;258 (3) :767-71.|[2]Kawagoe J, et al. Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats: a quantitative study. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345 (4) :485-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPC28531-01 20 µg
Recombinant Saccharomyces cerevisiae Alpha-1, 3-mannosyltransferase MNT3 (MNT3), partial
Sign In for Pricing
View Details RPC28531-02 100 µg
Recombinant Saccharomyces cerevisiae Alpha-1, 3-mannosyltransferase MNT3 (MNT3), partial
Sign In for Pricing
View Details RPC28531-03 1 mg
Recombinant Saccharomyces cerevisiae Alpha-1, 3-mannosyltransferase MNT3 (MNT3), partial
Sign In for Pricing
View Details 
50338141 1x 10^6 Cells / 1.0 mL
WDR47 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details